Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
slap on wrist for this POS ault
https://www.sec.gov/enforcement-litigation/administrative-proceedings/33-11222-s
and AULT is a 10% owner of MULN?
crooks of the feather flock together
$VXIT #VXIT on watch..0016 thin to 002s
expecting PR/8k by Friday
https://accesswire.com/889575/virexit-technologies-secures-landmark-agreement-for-maxclean-756-air-and-surface-purification-system-test-pilot-in-major-us-school-district-enhancing-indoor-air-and-mitigation-of-bacteria-viruses-toxic-molds-fungi-and-vocs-to-optimize-occupants………
huge buying OPP...bid 0008 now....when Jim's ready this moves fast to 005-01
I CANT wait till Jim announces CONTRACTS and REVENUES and WE get apologies from the doubters.
I'm sure next PR will have more details.
many know and will come as Jim builds a 300m dollar company...again
https://www.ukbusinessreporter.com/article/728687677-virexit-technologies-secures-agreement-for-maxclean-756-purification-system-test-pilot-in-major-u-s-school-district
https://www.greennewsuk.com/article/728687677-virexit-technologies-secures-agreement-for-maxclean-756-purification-system-test-pilot-in-major-u-s-school-district
https://www.ukeducationnewsnetwork.com/article/728687677-virexit-technologies-secures-agreement-for-maxclean-756-purification-system-test-pilot-in-major-u-s-school-district
https://www.evergreenstatepress.com/article/728687677-virexit-technologies-secures-agreement-for-maxclean-756-purification-system-test-pilot-in-major-u-s-school-district
https://www.theolympiaobserver.com/article/728687677-virexit-technologies-secures-agreement-for-maxclean-756-purification-system-test-pilot-in-major-u-s-school-district
https://www.washingtonindustryjournal.com/article/728687677-virexit-technologies-secures-agreement-for-maxclean-756-purification-system-test-pilot-in-major-u-s-school-district
https://www.washingtonstategazette.com/article/728687677-virexit-technologies-secures-agreement-for-maxclean-756-purification-system-test-pilot-in-major-u-s-school-district
https://www.entertainmentpresswashington.com/article/728687677-virexit-technologies-secures-agreement-for-maxclean-756-purification-system-test-pilot-in-major-u-s-school-district
https://www.unitedkingdomnewswatch.com/article/728687677-virexit-technologies-secures-agreement-for-maxclean-756-purification-system-test-pilot-in-major-u-s-school-district
https://www.unitedkingdomonlinenews.com/article/728687677-virexit-technologies-secures-agreement-for-maxclean-756-purification-system-test-pilot-in-major-u-s-school-district
https://www.newscenteruk.com/article/728687677-virexit-technologies-secures-agreement-for-maxclean-756-purification-system-test-pilot-in-major-u-s-school-district
https://www.ukheraldtribune.com/article/728687677-virexit-technologies-secures-agreement-for-maxclean-756-purification-system-test-pilot-in-major-u-s-school-district
https://www.ukpostobserver.com/article/728687677-virexit-technologies-secures-agreement-for-maxclean-756-purification-system-test-pilot-in-major-u-s-school-district
https://www.ukdailyledger.com/article/728687677-virexit-technologies-secures-agreement-for-maxclean-756-purification-system-test-pilot-in-major-u-s-school-district
https://www.breakingnewsfromtheuk.com/article/728687677-virexit-technologies-secures-agreement-for-maxclean-756-purification-system-test-pilot-in-major-u-s-school-district
https://www.unitedkingdomglobedispatch.com/article/728687677-virexit-technologies-secures-agreement-for-maxclean-756-purification-system-test-pilot-in-major-u-s-school-district
https://www.newswatchunitedkingdom.com/article/728687677-virexit-technologies-secures-agreement-for-maxclean-756-purification-system-test-pilot-in-major-u-s-school-district
https://www.ukdailynewsonline.com/article/728687677-virexit-technologies-secures-agreement-for-maxclean-756-purification-system-test-pilot-in-major-u-s-school-district
625,000,000 became 2 billion...unreal how this guy gets away with this
here look at this in $igpk
recently he had them unrestricted and live....cancelled my ass...dirty sewers for insiders01/11/2023 New Issuance 203,500,000 Common $.000735 No
***Brian McLain IR Services- Restricted
***IGPK has canceled this contract and is in the process of canceling these shares.
https://otcmarkets.com/otcapi/company/financial-report/374757/content
bashing? truth..I'm watching my investment get hammered and I'm not fing happy. dilution sux especially someone selling cancelled shares...
and my dad says Dwyer is a fing POS con artist as is NELSON....
The Agreed Judgment ordered Respondent McLain to pay $507,313.10, attorney's fees and expenses of $26,840.27 and postjudgment interest. v. The judgment has been outstanding at all times material hereto. e. On or about November 16, 2012, Bienvenu Investments 1, LLC, filed a lawsuit against Respondent McLain and M. McLain Investments, LLC, in Bienvenu Investments 1. LLC v. M. McLain Investments. LLC. et al., docket number C-20126195-A, in the 15th Judicial District Court of Lafayette Parish, Louisiana. The lawsuit alleged that the defendants leased a commercial building from the plaintiff and failed to tender timely payments. On January 22, 2013, the Court ordered judgment against Respondent McLain and M. McLain Investments, LLC, for $90,600.00 plus interest at a rate of eighteen percent plus $5,000 in attorney's fees. The judgment has been outstanding at all times material hereto.
I guess 203.5 m shares will be ATTACHED by his creditors or the SEC
https://ssb.state.tx.us/sites/default/files/files/news/1734.pdf
great job eric. looking more and more like a DWYER/NELSON/WU/MCLAIN robbery off DEJUNs back.
how he didnt cancel all their shares after gene is mind boggling
wowwwwwwwwww. cease and desist......how did Eric NEWLAN/dejun miss this?
princess just hates Jim...he has no factual ammo to support his bashing...
what will he say when pps goes to COPPER? silver?
delisting and BK inevitable. fraud of decade $muln
0012x0015....noone selling...come on alaska
sell to 0012 Alaska..and move on
GlobeStar is focused on efforts to obtain regulatory approvals for, and then commercialize, Project Amethyst™. Project Amethyst™ is a compound intended to treat neurodegeneration from MS, consisting of a patented custom drug cocktail of Minocycline, Fluconazole, and Atorvastatin. Each of these drugs has been approved by the FDA for separate applications. GSTC is the exclusive worldwide licensee for the all patents and patent applications relating to this compound.
GlobeStar is endeavoring to arrange financing to commence a study of the pharmacokinetic action of the three drugs, and then to initiate a clinical trial. Pharmacokinetics looks at changes in a drug after administration. A pharmacokinetic study generally requires from two weeks to eight weeks.
GlobeStar is discussing the parameters for a pharmacokinetic study with several Clinical Research Organizations (CRO's) in Europe and India. The CRO selected by GlobeStar would assist the company, SMI HealthCare LLC (SMIHC) and Advanced Innovative Partners (AIP) to develop a clinical trial plan. GlobeStar intends to seek FDA guidance in the development of that plan.
Following completion of the pharmacokinetic study, GlobeStar intends to arrange financing for SMIHC to manage an initial clinical trial in India, as well as regulatory filings, intellectual property rights filings, manufacturing, sales and distribution in India, Southeast Asia, Africa, and the Middle East. The clinical trial likely would require approximately three to six months. If results are positive, the trial would support regulatory clearance in India and potentially other countries, facilitating the Company's transition to revenues. Results also could be used to accelerate progress toward regulatory approval in the United States, though an additional trial likely would be required to obtain FDA approval.
It is anticipated that AIP will provide advice to GlobeStar and SMIHC on the global design, strategy and execution of clinical trials, regulatory filings, intellectual property rights filings, and manufacturing for Project Amethyst™.
GlobeStar is focused on efforts to obtain regulatory approvals for, and then commercialize, Project Amethyst™. Project Amethyst™ is a compound intended to treat neurodegeneration from MS, consisting of a patented custom drug cocktail of Minocycline, Fluconazole, and Atorvastatin. Each of these drugs has been approved by the FDA for separate applications. GSTC is the exclusive worldwide licensee for the all patents and patent applications relating to this compound.
GlobeStar is endeavoring to arrange financing to commence a study of the pharmacokinetic action of the three drugs, and then to initiate a clinical trial. Pharmacokinetics looks at changes in a drug after administration. A pharmacokinetic study generally requires from two weeks to eight weeks.
GlobeStar is discussing the parameters for a pharmacokinetic study with several Clinical Research Organizations (CRO's) in Europe and India. The CRO selected by GlobeStar would assist the company, SMI HealthCare LLC (SMIHC) and Advanced Innovative Partners (AIP) to develop a clinical trial plan. GlobeStar intends to seek FDA guidance in the development of that plan.
Following completion of the pharmacokinetic study, GlobeStar intends to arrange financing for SMIHC to manage an initial clinical trial in India, as well as regulatory filings, intellectual property rights filings, manufacturing, sales and distribution in India, Southeast Asia, Africa, and the Middle East. The clinical trial likely would require approximately three to six months. If results are positive, the trial would support regulatory clearance in India and potentially other countries, facilitating the Company's transition to revenues. Results also could be used to accelerate progress toward regulatory approval in the United States, though an additional trial likely would be required to obtain FDA approval.
It is anticipated that AIP will provide advice to GlobeStar and SMIHC on the global design, strategy and execution of clinical trials, regulatory filings, intellectual property rights filings, and manufacturing for Project Amethyst™.
californification.hang 10 baby........LFG Jim....copper-silver...m team needs a new Z06
0007 another buying OPP...low volume cleanup continues from scared money
slap ask 0012 with me in morning p$v? if not I'll bidsit waiting for the beer money flippers .....cleanup 000s in effect
$patience Pays .....Jim is building a company....we will ALL be rewarded as the contracts and revenues roll in
what part of it guy whose shares were supposed to be cancelled but were just CLEARED don't you get?
would you hold 204 million supposedly stolen shares worth 1 million dollars?
are you buying yet?
we are loaded and are bid sitting....at least I am....I can wait another year or two for silver ..whatever time it takes...I'm here for copper-silver since 2021...
waiting on updates...cheap AF here 0007-001 is GIFTS
seeking 006s...then copper---then silver....the foundation has been set...
IF YOU BUILD---THEY WILL COME
JIM is BUILDING a NEW COMPANY...
JIM WILL SUCCEED
tired of it..
exactly---dwyer/wu/nelson/ir guy getting 203.5 million shares after they were SUPPOSEDLY cancelled....what a MESS
do you call 6m in trades a selloff? you know better then that p&v
Mikey team VXIT...fighting the good fight while AHOLES with weak hands sell ...6m volume is scared flippers from 0008 buys who will miss the run back to 0023 on way to copper-silver
AS PER NEWLAN FILING....IGPK is a SHELL company. How in the blue hell did they get shares UNRESTRICTED EARLY especially ones that were supposedly cancelled?
https://www.otcmarkets.com/otcapi/company/financial-report/402059/content
agreed.and the IR guy 203.5 million.
and dejun only 1b shares smells like a 1b share payoff to be puppet CEO.
EXACTLY...post of the day!!!! otc37 gets it!!!
it will hit 006 before yours and Alaska's rebuy targets of 0005 lol...wanna bet?
if otc wasn't so dead we would be at 006 already.
the SEC will catch up to him soon.
and the doj
PPS should be 006s at this point!
hey IR guy...sell and run....in my worthless opinion